{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:46:42Z","timestamp":1783460802815,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jpet.2025.103611","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:37:33Z","timestamp":1747654653000},"page":"103611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alleviation of metabolic dysfunction\u2013associated steatotic liver disease by silymarin is associated with maintaining mitochondrial homeostasis via regulation of optic atrophy 1"],"prefix":"10.1016","volume":"392","author":[{"given":"Ming-qiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-bo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103611_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"issue":"10290","key":"10.1016\/j.jpet.2025.103611_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpet.2025.103611_bib3","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jpet.2025.103611_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.jpet.2025.103611_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.jpet.2025.103611_bib6","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.18632\/aging.102972","article-title":"Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"13","key":"10.1016\/j.jpet.2025.103611_bib7","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.3390\/ijms23137280","article-title":"Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease","volume":"23","author":"Ramanathan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103611_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-41342-6_2","article-title":"Silymarin and its role in chronic diseases","volume":"929","author":"Neha","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103611_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jvim.12002","article-title":"Milk thistle and its derivative compounds: a review of opportunities for treatment of liver disease","volume":"27","author":"Hackett","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"16","key":"10.1016\/j.jpet.2025.103611_bib10","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.3390\/molecules27165327","article-title":"Mechanistic insights into the pharmacological significance of silymarin","volume":"27","author":"Wadhwa","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jpet.2025.103611_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12906-021-03275-5","article-title":"Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male Albino Wistar rats","volume":"21","author":"Mengesha","year":"2021","journal-title":"BMC Complement Med Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103611_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1590\/1414-431X20122551","article-title":"Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver","volume":"46","author":"Yao","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jpet.2025.103611_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopha.2018.01.144","article-title":"Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice","volume":"100","author":"Zhu","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jpet.2025.103611_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41401-022-00924-4","article-title":"Silybin regulates P450s activity by attenuating endoplasmic reticulum stress in mouse nonalcoholic fatty liver disease","volume":"44","author":"Wu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jpet.2025.103611_bib15","article-title":"Silibinin ameliorates deoxycholic acid-induced pyroptosis in steatotic HepG2 cells by inhibiting NLRP3 inflammasome activation","volume":"35","author":"Mai","year":"2023","journal-title":"Biochem Biophys Rep"},{"issue":"1-2","key":"10.1016\/j.jpet.2025.103611_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-1218(85)90029-1","article-title":"Inability of chrysotile asbestos fibers to modulate the 2-acetylaminofluorene-induced UDS in primary cultures of rat hepatocytes","volume":"155","author":"Denizeau","year":"1985","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103611_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/BJ20100671","article-title":"Epidermal growth factor down-regulates the expression of human hepatic stimulator substance via CCAAT\/enhancer-binding protein \u03b2 in HepG2 cells","volume":"431","author":"Dong","year":"2010","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.jpet.2025.103611_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2014.10.008","article-title":"Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice","volume":"148","author":"Gandhi","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jpet.2025.103611_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41388-022-02549-7","article-title":"Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma","volume":"42","author":"Zheng","year":"2023","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.jpet.2025.103611_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41419-022-05395-3","article-title":"Tubular \u03b2-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.jpet.2025.103611_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18449","article-title":"ARMC10 regulates mitochondrial dynamics and affects mitochondrial function via the Wnt\/\u03b2-catenin signalling pathway involved in ischaemic stroke","volume":"28","author":"Huang","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.jpet.2025.103611_bib22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0092-8674(00)80352-9","article-title":"Three-dimensional structure of the armadillo repeat region of beta-catenin","volume":"90","author":"Huber","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jpet.2025.103611_bib23","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/med.21787","article-title":"Direct targeting of \u03b2-catenin in the Wnt signaling pathway: current progress and perspectives","volume":"41","author":"Wang","year":"2021","journal-title":"Med Res Rev"},{"issue":"6","key":"10.1016\/j.jpet.2025.103611_bib24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver disease: a systematic review and meta-analysis","volume":"113","author":"Jacobs","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jpet.2025.103611_bib25","doi-asserted-by":"crossref","first-page":"nep164","DOI":"10.1093\/ecam\/nep164","article-title":"Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis","volume":"2011","author":"Haddad","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"10.1016\/j.jpet.2025.103611_bib26","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1007\/s10620-018-5268-0","article-title":"Silybin alleviates hepatic steatosis and fibrosis in NASH mice by inhibiting oxidative stress and involvement with the Nf-\u03baB pathway","volume":"63","author":"Ou","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.jpet.2025.103611_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159729","article-title":"Investigating nonalcoholic fatty liver disease in a Liver-on-a-Chip microfluidic device","volume":"11","author":"Gori","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jpet.2025.103611_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/ajcn\/76.4.750","article-title":"Adipose tissue biomarkers of fatty acid intake","volume":"76","author":"Baylin","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.jpet.2025.103611_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103549","article-title":"In vitro models for non-alcoholic fatty liver disease: emerging platforms and their applications","volume":"25","author":"Ramos","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jpet.2025.103611_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-nutr-071715-050656","article-title":"Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus","volume":"36","author":"Koliaki","year":"2016","journal-title":"Annu Rev Nutr"},{"issue":"16","key":"10.1016\/j.jpet.2025.103611_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900043","article-title":"Mitochondria-mediated pathogenesis and therapeutics for non-alcoholic fatty liver disease","volume":"63","author":"Li","year":"2019","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"10.1016\/j.jpet.2025.103611_bib32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/antiox11061101","article-title":"Silibinin protects against H2O2-induced oxidative damage in SH-SY5Y cells by improving mitochondrial function","volume":"11","author":"Tie","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.jpet.2025.103611_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41419-018-0718-3","article-title":"RAGE-dependent mitochondria pathway: a novel target of silibinin against apoptosis of osteoblastic cells induced by advanced glycation end products","volume":"9","author":"Mao","year":"2018","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.jpet.2025.103611_bib34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jcpe.13811","article-title":"Activation of PGC-1\u03b1-dependent mitochondrial biogenesis supports therapeutic effects of silibinin against type I diabetic periodontitis","volume":"50","author":"Sun","year":"2023","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.jpet.2025.103611_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101273","article-title":"Endothelial arginase 2 mediates retinal ischemia\/reperfusion injury by inducing mitochondrial dysfunction","volume":"53","author":"Shosha","year":"2021","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.jpet.2025.103611_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","article-title":"Mitochondrial dynamics and metabolic regulation","volume":"27","author":"Wai","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jpet.2025.103611_bib37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.22183","article-title":"The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity","volume":"47","author":"Li","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jpet.2025.103611_bib38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1083\/jcb.201007152","article-title":"Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells","volume":"191","author":"Otera","year":"2010","journal-title":"J Cell Biol"},{"issue":"8","key":"10.1016\/j.jpet.2025.103611_bib39","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/1873-3468.14077","article-title":"Mitochondrial dynamics in health and disease","volume":"595","author":"Yapa","year":"2021","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.jpet.2025.103611_bib40","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2025.103611_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-8-32","article-title":"Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics","volume":"8","author":"Alavi","year":"2013","journal-title":"Mol Neurodegener"},{"issue":"7","key":"10.1016\/j.jpet.2025.103611_bib42","article-title":"Tumor cell-intrinsic CD96 mediates chemoresistance and cancer stemness by regulating mitochondrial fatty acid \u03b2-oxidation","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"10.1016\/j.jpet.2025.103611_bib43","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/hepr.12634","article-title":"Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1\/SIRT3-FOXO3a pathway","volume":"46","author":"Tong","year":"2016","journal-title":"Hepatol Res"},{"issue":"10","key":"10.1016\/j.jpet.2025.103611_bib44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3724\/abbs.2022146","article-title":"Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1\/Opa1 signalling pathway","volume":"54","author":"Xu","year":"2022","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4","key":"10.1016\/j.jpet.2025.103611_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2018.06.014","article-title":"Mitochondrial stasis reveals p62-mediated ubiquitination in parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease","volume":"28","author":"Yamada","year":"2018","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.jpet.2025.103611_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103996","article-title":"Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver","volume":"25","author":"Yamada","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jpet.2025.103611_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105330","article-title":"Protective effects of silibinin against ethanol- or acetaldehyde-caused damage in liver cell lines involve the repression of mitochondrial fission","volume":"80","author":"Song","year":"2022","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"10.1016\/j.jpet.2025.103611_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.hbpd.2022.10.003","article-title":"Wnt\/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases","volume":"22","author":"Shree Harini","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jpet.2025.103611_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.791861","article-title":"Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt\/\u03b2-catenin signal pathway","volume":"8","author":"Li","year":"2021","journal-title":"Front Nutr"},{"issue":"3","key":"10.1016\/j.jpet.2025.103611_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.4609","article-title":"Silibinin-loaded nanoparticles for drug delivery in gastric cancer: in vitro modulating miR-181a and miR-34a to inhibit cancer cell growth and migration","volume":"13","author":"Karami Fath","year":"2025","journal-title":"Food Sci Nutr"},{"issue":"7","key":"10.1016\/j.jpet.2025.103611_bib51","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"\u03b2-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:32:39Z","timestamp":1762209159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0022356525398241"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103611","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alleviation of metabolic dysfunction\u2013associated steatotic liver disease by silymarin is associated with maintaining mitochondrial homeostasis via regulation of optic atrophy 1","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103611"}}